Member of Lyonbiopole
KUSTE BIOPHARMA is a biopharmaceutical Clinical Stage company recently founded by seasoned Life Sciences entrepreneurs, inheriting anti-inflammatory compounds locally released, that have achieved results in Phase 3 for eye and ears diseases. KUSTE BIOPHARMA is expanding the use of these molecules to inflammatory Uro-Gastro diseases whose medical needs are currently unmet, such as Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). Existing data support also other possible developments, like Inflammatory Bowel Disease (IBD). KUSTE BIOPHARMA has closed a relevant financial round entering Phase 2 clinical studies on IC/PBS.
Strategic application domain: Human Medicine
Application market: Others
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Others
Created on may 7th, 2020 - 5 employees
Address
Tour Part-Dieu, 129 rue Servient 69326 Lyon Lyon cedex 3
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.